What is it about?

To avoid shut down of cancer screening institutions is crucial. We found the level of acceptable lower limit of screening rates for colorectal cancer. The results could be used as evidence for continuity of cancer screening under pandemic situation.

Featured Image

Why is it important?

Our findings suggest evidence based acceptable screening rates for colorectal cancer. These 'true' acceptable rate could be used as evidence for continuity of cancer screening under pandemic situation. Additionally, for those regions where screening rates are not sufficiently high, the results could serve as immediate targets. Furthermore, the minimum requirement for stool test rate could be a benchmark for shifting to fecal immunochemical test (FIT) focused operation.

Perspectives

This study focused primarily on pandemic-resilient target setting in colorectal cancer screening, however the results could also be applied to target setting in normal times, with replacing currently used acceptable levels by evidence-based minimum requirements.

Toshiaki Shibata
Tokyo Medical and Dental University

Read the Original

This page is a summary of: Pandemic‐resilient target setting in colorectal cancer screening for vulnerable older population, Cancer Medicine, June 2022, Wiley, DOI: 10.1002/cam4.4907.
You can read the full text:

Read

Contributors

The following have contributed to this page